Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO15443 | Ailanthus altissima | Species | Simaroubaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 169900 | nM | 20863599 |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 2511.9 | nM | PubChem BioAssay data set |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 20587.8 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 92.8 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 4256.2 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 26915.35 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 83176.38 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 66069.34 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 70957.78 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 83368.12 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 94841.85 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 65765.78 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 71944.9 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 49431.07 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 74473.2 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 77803.66 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 58076.44 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 61659.5 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 90782.05 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 65463.62 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 78886.01 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 730.8 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 8199.5 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 4466.8 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC130655 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.6806 | Remote Similarity | NPC314278 |
0.6794 | Remote Similarity | NPC38262 |
0.6786 | Remote Similarity | NPC226143 |
0.6781 | Remote Similarity | NPC477432 |
0.6767 | Remote Similarity | NPC172170 |
0.6645 | Remote Similarity | NPC470822 |
0.6594 | Remote Similarity | NPC57051 |
0.6554 | Remote Similarity | NPC314431 |
0.6554 | Remote Similarity | NPC280807 |
0.6528 | Remote Similarity | NPC39818 |
0.6512 | Remote Similarity | NPC175376 |
0.6507 | Remote Similarity | NPC470343 |
0.6507 | Remote Similarity | NPC472244 |
0.6376 | Remote Similarity | NPC150863 |
0.6369 | Remote Similarity | NPC478040 |
0.6333 | Remote Similarity | NPC472245 |
0.6333 | Remote Similarity | NPC187231 |
0.6327 | Remote Similarity | NPC192533 |
0.6267 | Remote Similarity | NPC209389 |
0.6259 | Remote Similarity | NPC254698 |
0.6259 | Remote Similarity | NPC2982 |
0.6233 | Remote Similarity | NPC257490 |
0.6207 | Remote Similarity | NPC177684 |
0.6207 | Remote Similarity | NPC291962 |
0.619 | Remote Similarity | NPC268534 |
0.6184 | Remote Similarity | NPC314473 |
0.6174 | Remote Similarity | NPC205946 |
0.6164 | Remote Similarity | NPC150323 |
0.6164 | Remote Similarity | NPC258531 |
0.6164 | Remote Similarity | NPC179605 |
0.6164 | Remote Similarity | NPC161956 |
0.6164 | Remote Similarity | NPC279385 |
0.6164 | Remote Similarity | NPC112373 |
0.6154 | Remote Similarity | NPC328270 |
0.6133 | Remote Similarity | NPC322433 |
0.6122 | Remote Similarity | NPC103292 |
0.6119 | Remote Similarity | NPC323726 |
0.608 | Remote Similarity | NPC307163 |
0.6029 | Remote Similarity | NPC24122 |
0.5988 | Remote Similarity | NPC472242 |
0.5987 | Remote Similarity | NPC58827 |
0.5987 | Remote Similarity | NPC72473 |
0.5987 | Remote Similarity | NPC307437 |
0.5986 | Remote Similarity | NPC181390 |
0.5975 | Remote Similarity | NPC472243 |
0.5974 | Remote Similarity | NPC314098 |
0.5949 | Remote Similarity | NPC159722 |
0.5938 | Remote Similarity | NPC471164 |
0.5901 | Remote Similarity | NPC472241 |
0.5875 | Remote Similarity | NPC207554 |
0.5871 | Remote Similarity | NPC316746 |
0.5865 | Remote Similarity | NPC291070 |
0.5865 | Remote Similarity | NPC246757 |
0.5828 | Remote Similarity | NPC190945 |
0.5828 | Remote Similarity | NPC282578 |
0.5828 | Remote Similarity | NPC314186 |
0.5811 | Remote Similarity | NPC229353 |
0.5806 | Remote Similarity | NPC194562 |
0.5789 | Remote Similarity | NPC226794 |
0.5781 | Remote Similarity | NPC470794 |
0.576 | Remote Similarity | NPC300205 |
0.5758 | Remote Similarity | NPC478039 |
0.5742 | Remote Similarity | NPC122235 |
0.5741 | Remote Similarity | NPC471574 |
0.5733 | Remote Similarity | NPC130931 |
0.5732 | Remote Similarity | NPC40364 |
0.5726 | Remote Similarity | NPC245966 |
0.5714 | Remote Similarity | NPC164086 |
0.5714 | Remote Similarity | NPC319645 |
0.5714 | Remote Similarity | NPC71664 |
0.5703 | Remote Similarity | NPC273758 |
0.5703 | Remote Similarity | NPC471895 |
0.5682 | Remote Similarity | NPC176858 |
0.568 | Remote Similarity | NPC36342 |
0.568 | Remote Similarity | NPC2785 |
0.568 | Remote Similarity | NPC285470 |
0.5679 | Remote Similarity | NPC242933 |
0.5669 | Remote Similarity | NPC273033 |
0.5669 | Remote Similarity | NPC12936 |
0.5639 | Remote Similarity | NPC191444 |
0.5639 | Remote Similarity | NPC470797 |
0.5636 | Remote Similarity | NPC136002 |
0.5633 | Remote Similarity | NPC207428 |
0.5633 | Remote Similarity | NPC23908 |
0.5621 | Remote Similarity | NPC314223 |
0.5606 | Remote Similarity | NPC30445 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC130655 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7619 | Intermediate Similarity | NPD1518 | Clinical (unspecified phase) |
0.7347 | Intermediate Similarity | NPD1222 | Discontinued |
0.7078 | Intermediate Similarity | NPD1890 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD2413 | Phase 2 |
0.6966 | Remote Similarity | NPD1190 | Approved |
0.6939 | Remote Similarity | NPD1588 | Clinical (unspecified phase) |
0.6894 | Remote Similarity | NPD1868 | Discontinued |
0.6846 | Remote Similarity | NPD5227 | Clinical (unspecified phase) |
0.6726 | Remote Similarity | NPD3948 | Discontinued |
0.6713 | Remote Similarity | NPD3355 | Approved |
0.6713 | Remote Similarity | NPD3356 | Approved |
0.6623 | Remote Similarity | NPD3482 | Approved |
0.6554 | Remote Similarity | NPD2918 | Clinical (unspecified phase) |
0.6554 | Remote Similarity | NPD2919 | Clinical (unspecified phase) |
0.6549 | Remote Similarity | NPD1245 | Approved |
0.6547 | Remote Similarity | NPD1246 | Approved |
0.6538 | Remote Similarity | NPD4043 | Approved |
0.6538 | Remote Similarity | NPD3481 | Approved |
0.6538 | Remote Similarity | NPD4046 | Approved |
0.6536 | Remote Similarity | NPD7142 | Discontinued |
0.6533 | Remote Similarity | NPD441 | Approved |
0.6491 | Remote Similarity | NPD5755 | Clinical (unspecified phase) |
0.6475 | Remote Similarity | NPD1175 | Approved |
0.638 | Remote Similarity | NPD4042 | Phase 2 |
0.638 | Remote Similarity | NPD4045 | Phase 2 |
0.6369 | Remote Similarity | NPD4645 | Clinical (unspecified phase) |
0.6352 | Remote Similarity | NPD1956 | Clinical (unspecified phase) |
0.6346 | Remote Similarity | NPD4461 | Discontinued |
0.6345 | Remote Similarity | NPD1079 | Discontinued |
0.6243 | Remote Similarity | NPD3910 | Clinical (unspecified phase) |
0.6234 | Remote Similarity | NPD1410 | Phase 1 |
0.6234 | Remote Similarity | NPD2331 | Discontinued |
0.6233 | Remote Similarity | NPD1123 | Approved |
0.6233 | Remote Similarity | NPD1124 | Approved |
0.622 | Remote Similarity | NPD737 | Phase 2 |
0.6216 | Remote Similarity | NPD1640 | Clinical (unspecified phase) |
0.6216 | Remote Similarity | NPD9539 | Approved |
0.6216 | Remote Similarity | NPD9541 | Approved |
0.6205 | Remote Similarity | NPD5659 | Approved |
0.6205 | Remote Similarity | NPD5660 | Approved |
0.6205 | Remote Similarity | NPD6019 | Approved |
0.6205 | Remote Similarity | NPD6018 | Approved |
0.6201 | Remote Similarity | NPD6891 | Phase 2 |
0.6185 | Remote Similarity | NPD2461 | Phase 1 |
0.6184 | Remote Similarity | NPD486 | Clinical (unspecified phase) |
0.6178 | Remote Similarity | NPD5068 | Clinical (unspecified phase) |
0.6164 | Remote Similarity | NPD9272 | Approved |
0.6159 | Remote Similarity | NPD445 | Discontinued |
0.6144 | Remote Similarity | NPD9471 | Clinical (unspecified phase) |
0.6136 | Remote Similarity | NPD1478 | Clinical (unspecified phase) |
0.6133 | Remote Similarity | NPD9540 | Approved |
0.6133 | Remote Similarity | NPD9567 | Approved |
0.6133 | Remote Similarity | NPD552 | Approved |
0.6133 | Remote Similarity | NPD553 | Approved |
0.6131 | Remote Similarity | NPD5992 | Approved |
0.6129 | Remote Similarity | NPD5258 | Approved |
0.6129 | Remote Similarity | NPD5260 | Approved |
0.6095 | Remote Similarity | NPD9487 | Approved |
0.6078 | Remote Similarity | NPD1619 | Phase 3 |
0.6071 | Remote Similarity | NPD5278 | Discontinued |
0.6071 | Remote Similarity | NPD3388 | Phase 1 |
0.6062 | Remote Similarity | NPD4464 | Clinical (unspecified phase) |
0.6061 | Remote Similarity | NPD1854 | Approved |
0.6056 | Remote Similarity | NPD1279 | Clinical (unspecified phase) |
0.6056 | Remote Similarity | NPD181 | Approved |
0.6053 | Remote Similarity | NPD4549 | Discontinued |
0.6053 | Remote Similarity | NPD1781 | Discontinued |
0.6027 | Remote Similarity | NPD483 | Approved |
0.6026 | Remote Similarity | NPD797 | Clinical (unspecified phase) |
0.6023 | Remote Similarity | NPD3449 | Discontinued |
0.6014 | Remote Similarity | NPD1280 | Clinical (unspecified phase) |
0.6012 | Remote Similarity | NPD3753 | Suspended |
0.6011 | Remote Similarity | NPD6659 | Phase 2 |
0.6 | Remote Similarity | NPD6566 | Discontinued |
0.5978 | Remote Similarity | NPD7786 | Discontinued |
0.5976 | Remote Similarity | NPD1004 | Phase 2 |
0.5976 | Remote Similarity | NPD1005 | Phase 2 |
0.596 | Remote Similarity | NPD1574 | Approved |
0.5943 | Remote Similarity | NPD1925 | Approved |
0.5939 | Remote Similarity | NPD921 | Discontinued |
0.5938 | Remote Similarity | NPD3434 | Clinical (unspecified phase) |
0.593 | Remote Similarity | NPD3252 | Approved |
0.5926 | Remote Similarity | NPD5918 | Discontinued |
0.5921 | Remote Similarity | NPD1593 | Approved |
0.5906 | Remote Similarity | NPD5770 | Phase 3 |
0.5903 | Remote Similarity | NPD2587 | Approved |
0.5897 | Remote Similarity | NPD1527 | Phase 2 |
0.5897 | Remote Similarity | NPD4680 | Discontinued |
0.5897 | Remote Similarity | NPD1541 | Approved |
0.5897 | Remote Similarity | NPD1874 | Clinical (unspecified phase) |
0.5876 | Remote Similarity | NPD3325 | Approved |
0.5868 | Remote Similarity | NPD2501 | Discontinued |
0.5867 | Remote Similarity | NPD2389 | Approved |
0.5844 | Remote Similarity | NPD5442 | Approved |
0.5833 | Remote Similarity | NPD2512 | Phase 3 |
0.5828 | Remote Similarity | NPD2435 | Approved |
0.5808 | Remote Similarity | NPD8314 | Clinical (unspecified phase) |
0.5802 | Remote Similarity | NPD6768 | Approved |
0.5802 | Remote Similarity | NPD2365 | Approved |
0.5786 | Remote Similarity | NPD5004 | Approved |
0.5783 | Remote Similarity | NPD1971 | Approved |
0.5783 | Remote Similarity | NPD1970 | Approved |
0.578 | Remote Similarity | NPD1545 | Discontinued |
0.5778 | Remote Similarity | NPD3327 | Approved |
0.5775 | Remote Similarity | NPD7156 | Discontinued |
0.5774 | Remote Similarity | NPD3399 | Approved |
0.5767 | Remote Similarity | NPD2820 | Phase 3 |
0.5765 | Remote Similarity | NPD2000 | Phase 3 |
0.5765 | Remote Similarity | NPD1999 | Phase 3 |
0.5762 | Remote Similarity | NPD4478 | Clinical (unspecified phase) |
0.5758 | Remote Similarity | NPD4041 | Approved |
0.5756 | Remote Similarity | NPD3747 | Discontinued |
0.575 | Remote Similarity | NPD2670 | Approved |
0.5742 | Remote Similarity | NPD766 | Clinical (unspecified phase) |
0.5741 | Remote Similarity | NPD2750 | Approved |
0.5741 | Remote Similarity | NPD2010 | Phase 3 |
0.574 | Remote Similarity | NPD5189 | Clinical (unspecified phase) |
0.5739 | Remote Similarity | NPD3305 | Discontinued |
0.5737 | Remote Similarity | NPD7995 | Phase 2 |
0.5735 | Remote Similarity | NPD1099 | Approved |
0.5735 | Remote Similarity | NPD716 | Approved |
0.5735 | Remote Similarity | NPD1100 | Approved |
0.5724 | Remote Similarity | NPD5702 | Clinical (unspecified phase) |
0.5722 | Remote Similarity | NPD3770 | Phase 2 |
0.5714 | Remote Similarity | NPD3170 | Approved |
0.5714 | Remote Similarity | NPD4643 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD6655 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD1110 | Approved |
0.5714 | Remote Similarity | NPD1007 | Discontinued |
0.5714 | Remote Similarity | NPD1109 | Approved |
0.5714 | Remote Similarity | NPD4100 | Approved |
0.5714 | Remote Similarity | NPD4099 | Approved |
0.5714 | Remote Similarity | NPD710 | Clinical (unspecified phase) |
0.5706 | Remote Similarity | NPD6193 | Clinical (unspecified phase) |
0.5706 | Remote Similarity | NPD2923 | Approved |
0.5706 | Remote Similarity | NPD7663 | Clinical (unspecified phase) |
0.5705 | Remote Similarity | NPD430 | Discontinued |
0.5697 | Remote Similarity | NPD2887 | Clinical (unspecified phase) |
0.5697 | Remote Similarity | NPD6185 | Discontinued |
0.5696 | Remote Similarity | NPD6740 | Clinical (unspecified phase) |
0.5691 | Remote Similarity | NPD4342 | Phase 2 |
0.5685 | Remote Similarity | NPD456 | Approved |
0.5676 | Remote Similarity | NPD1596 | Approved |
0.5676 | Remote Similarity | NPD3907 | Clinical (unspecified phase) |
0.5674 | Remote Similarity | NPD2192 | Approved |
0.5674 | Remote Similarity | NPD2197 | Approved |
0.5674 | Remote Similarity | NPD745 | Clinical (unspecified phase) |
0.5673 | Remote Similarity | NPD5634 | Approved |
0.5669 | Remote Similarity | NPD942 | Approved |
0.5667 | Remote Similarity | NPD918 | Approved |
0.5667 | Remote Similarity | NPD5840 | Discontinued |
0.5663 | Remote Similarity | NPD4607 | Approved |
0.566 | Remote Similarity | NPD1531 | Approved |
0.5652 | Remote Similarity | NPD6342 | Discontinued |
0.5649 | Remote Similarity | NPD2056 | Discontinued |
0.5647 | Remote Similarity | NPD512 | Approved |
0.5647 | Remote Similarity | NPD511 | Approved |
0.5638 | Remote Similarity | NPD457 | Approved |
0.5634 | Remote Similarity | NPD9702 | Discontinued |
0.5629 | Remote Similarity | NPD3352 | Approved |
0.5629 | Remote Similarity | NPD1525 | Approved |
0.5629 | Remote Similarity | NPD6758 | Approved |
0.5625 | Remote Similarity | NPD1317 | Discontinued |
0.5625 | Remote Similarity | NPD1559 | Discontinued |
0.5618 | Remote Similarity | NPD5633 | Discontinued |
0.5616 | Remote Similarity | NPD5277 | Phase 2 |
0.5616 | Remote Similarity | NPD1267 | Approved |
0.5616 | Remote Similarity | NPD1265 | Approved |
0.5611 | Remote Similarity | NPD3004 | Clinical (unspecified phase) |
0.5602 | Remote Similarity | NPD5933 | Phase 3 |
0.5602 | Remote Similarity | NPD5932 | Phase 3 |
0.5602 | Remote Similarity | NPD6017 | Discontinued |
0.5602 | Remote Similarity | NPD5931 | Phase 3 |
0.56 | Remote Similarity | NPD923 | Approved |
0.56 | Remote Similarity | NPD1668 | Clinical (unspecified phase) |
PubChem CID   | 5377530 |
ChEMBL   | CHEMBL1288971 |
ZINC   |
Molecular Weight:   | 259.03 |
ALogP:   | 1.348 |
MLogP:   | 2.34 |
XLogP:   | 4.223 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 88.45 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 2 |
# Heavy Atoms:   | 18 |